BLCO vs MSCI · rev $5.10B vs P/E 37, rev $1.72B
Bausch + Lomb Corp (BLCO) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported BLCO revenue for 2025-12-31 was $5.10B. Net income was -$360.0M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BLCO currently screens at market cap $5.38B.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
BLCO currently screens at market cap $5.38B. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the BLCO and MSCI stock pages for the full models.
Not investment advice.